Liquidia Technologies LQDA 深 滬
已收盤 05-08 16:00:00 美东时间
42.30
+0.020
+0.05%
華盛通- 最 高42.94
- 今 開42.04
- 成交量 150.79万股
- 最 低 41.06
- 昨 收 42.28
- 總市值 37.60亿
- 52周最高 46.67
- 市盈率 靜 --
- 換手率 1.70%
- 52周最低 11.85
- 委 比 72.01%
- 總股本 8889.36万
- 歷史最高 46.67
- 量 比 1.56
- 振 幅 4.45%
- 歷史最低 2.25
- 每 手 1
- 風險率 9.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
05-07 01:35
Summers Value Fund adds TBPH, exits ADMA among Q1 moves
The Summers Value Fund LP returned -2.7% net in Q1 2026, underperforming the Russell 2000 Index ETF, which returned 0.9%, and the Russell 2000 Value Index ETF, which returned 4.9%. According to its qu...
04-29 23:26
Liquidia CFO/COO Michael Kaseta disposes of common shares worth $5.69 million
Liquidia CFO/COO Michael Kaseta disposes of common shares worth $5.69 million Liquidia CFO and COO Michael Kaseta reported sales totaling 142,390 shares on April 14-15. Sales priced at USD 40 per share on April 14. April 15 disposals priced at USD 40.14 per share. Kaseta reported 353,356 shares bene
04-17 08:38
United Therapeutics surges on Tyvaso results for idiopathic pulmonary fibrosis
United Therapeutics is up ~12% in Monday morning trading after reporting positive results in a pair of studies examining Tyvaso (treprostinil) for idiopathic pulmonary fibrosis. In TETON-1, Tyvaso met...
03-30 23:41
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
U.S. stocks ended Friday broadly lower, with selling pressure intensifying across sectors as investors weighed persistent geopolitical risks tied to tensions in the Middle East. The tech-focused Nasda...
03-29 21:05
美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元
今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元
03-24 10:07
Wells Fargo Maintains Overweight on Liquidia, Raises Price Target to $51
Wells Fargo analyst Benjamin Burnett maintains Liquidia (NASDAQ:LQDA) with a Overweight and raises the price target from $44 to $51.
03-23 21:20
美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
United Therapeutics's board approves new $2B repurchase authorization; prices $1.5B ASR
United Therapeutics Corporation (UTHR) announced a stock repurchase program authorized by its board of directors, allowing for up to $2 billion in buybacks over the next year. The company has also sig...
03-09 19:37
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
